Katexin

Katexin is a financial entity registered in the United Kingdom, founded on 20 November 2019. The official domain for the company is katexin.com. Based on available records, the firm does not hold any recognised regulatory licences or authorisations from UK or international financial authorities.

Given the absence of regulatory oversight, Katexin operates with minimal external scrutiny. This lack of supervision raises significant concerns for potential clients, as there is no mandated framework to ensure fair trading practices or the safeguarding of client funds.

Our research indicates that Katexin has no regulators on file. This means the company is not authorised by the Financial Conduct Authority (FCA) in the UK or any equivalent body elsewhere.

Without regulatory oversight, traders have no recourse to compensation schemes such as the Financial Services Compensation Scheme (FSCS) in the UK. This absence of protection is a critical factor for anyone considering engaging with this broker.

FXCanary's internal risk scoring has assigned Katexin a Scam Risk Score of 75 out of 100, categorised as 'Severe'. This high score is primarily driven by the complete lack of regulatory licensing and the limited public information about the firm's operations.

Traders are strongly advised to exercise extreme caution. The combination of an unregulated status and a high-risk score suggests a heightened probability of fraudulent or unethical practices.

Katexin presents a high-risk profile due to its unregulated status and the absence of verifiable operational history beyond its registration date. As of this review, there is no independent user feedback or publicly available information about its trading platforms, account types, or customer service.

Prospective clients should treat this broker with extreme scepticism. It is recommended to only engage with brokers that are properly regulated by reputable authorities to ensure a minimum level of security and accountability.